How Clinic-Ready Manufacturing and Adaptive Clinical Trials Can Reduce Drug Development Timelines
The complexities of active pharmaceutical ingredient (API) formulation, product testing, and documentation requirements can hinder the speed at which a promising drug candidate progresses to and through clinical trials.